Top compounds associated with response to NTMT1


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0002
mRNA paclitaxel CCLE pan-cancer AAC 0.16 0.0003
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0003
mRNA thapsigargin gCSI pan-cancer AAC 0.21 0.0003
mRNA NVP-BSK805 CTRPv2 pan-cancer AAC -0.12 0.0004
mRNA OSU-03012 GDSC1000 pan-cancer AAC 0.12 0.0006
mRNA SKI-II CTRPv2 pan-cancer AAC -0.13 0.0006
mRNA lovastatin CTRPv2 pan-cancer AAC 0.13 0.0006
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.12 0.0007
mRNA PX-12 CTRPv2 pan-cancer AAC -0.099 0.0007
Download CSV